Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): Randomised, placebo controlled, crossover study

British Medical Journal

Volumn 322, Issue 7277, 2001, Pages 19-22

  Schrader, H ^a   Stovner, L J ^a   Helde, G ^a   Sand, T ^a   Bovim, G ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; LISINOPRIL; METHYSERGIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIZOTIFEN; SEROTONIN ANTAGONIST; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SYNCOPE; VERTIGO;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; LISINOPRIL; MALE; MIDDLE AGED; MIGRAINE DISORDERS; STATISTICS, NONPARAMETRIC;

EID: 0035814597     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. National confidential enquiry into counselling for genetic disorders by non-geneticists: General recommendations and specific standards for improving care